المؤلفون: Hendriks, L. E., Kerr, K. M., Menis, J., Mok, T. S., Nestle, U., Passaro, A., Peters, S., Planchard, D., Smit, E. F., Solomon, B. J., Veronesi, G., Reck, M., Guidelines Committee, ESMO

المصدر: Hendriks , L E , Kerr , K M , Menis , J , Mok , T S , Nestle , U , Passaro , A , Peters , S , Planchard , D , Smit , E F , Solomon , B J , Veronesi , G , Reck , M , ESMO Guidelines Committee & Guidelines Committee , ESMO 2023 , ' Oncogene-addicted metastatic non-small-cell lung cancer : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ' , Annals of Oncology , vol. 34 , no. 4 , pp. 339-357 . https://doi.org/10.1016/j.annonc.2022.12.009Test

مصطلحات موضوعية: ESCAT, ESMO Clinical Practice Guideline (CPG), ESMO-MCBS, oncogene-addicted metastatic non-small-cell lung cancer (mNSCLC), treatment, targeted therapy, TYROSINE KINASE INHIBITORS, PROGRESSION-FREE SURVIVAL, RESPONSE EVALUATION CRITERIA, FACTOR RECEPTOR MUTATIONS, OPEN-LABEL, 1ST-LINE TREATMENT, SINGLE-ARM, TREATMENT-NAIVE, EGFR MUTATIONS, ADVANCED NSCLC

وصف الملف: application/pdf

العلاقة: https://cris.maastrichtuniversity.nl/en/publications/a6c20759-e209-411f-b9b7-789fc32e2f64Test

الإتاحة: https://doi.org/10.1016/j.annonc.2022.12.009Test
https://cris.maastrichtuniversity.nl/en/publications/a6c20759-e209-411f-b9b7-789fc32e2f64Test
https://cris.maastrichtuniversity.nl/ws/files/192165782/Hendriks-2023-Oncogene-addicted-metastatic-non-small.pdfTest

المؤلفون: Hendriks, L. E., Kerr, K. M., Menis, J., Mok, T. S., Nestle, U., Passaro, A., Planchard, D., Peters, S., Smit, E. F., Solomon, B. J., Veronesi, G., Reck, M., Guidelines Committee, ESMO

المصدر: Hendriks , L E , Kerr , K M , Menis , J , Mok , T S , Nestle , U , Passaro , A , Planchard , D , Peters , S , Smit , E F , Solomon , B J , Veronesi , G , Reck , M , ESMO Guidelines Committee & Guidelines Committee , ESMO 2023 , ' Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ' , Annals of Oncology , vol. 34 , no. 4 , pp. 358-376 . https://doi.org/10.1016/j.annonc.2022.12.013Test

مصطلحات موضوعية: ESCAT, ESMO Clinical Practice Guideline (CPG), ESMO-MCBS, non-oncogene-addicted metastatic non-small-cell lung cancer (mNSCLC), treatment, targeted therapy, immunotherapy, RANDOMIZED PHASE-III, QUALITY-OF-LIFE, PACLITAXEL DOUBLET CHEMOTHERAPY, RESPONSE EVALUATION CRITERIA, PLATINUM-BASED CHEMOTHERAPY, PEMETREXED PLUS CISPLATIN, SPECIFIED FINAL ANALYSIS, INDIVIDUAL PATIENT DATA, ELDERLY-PATIENTS, 2ND-LINE TREATMENT

وصف الملف: application/pdf

العلاقة: https://cris.maastrichtuniversity.nl/en/publications/7f71c7db-b119-4345-a38e-5b383cefe585Test

الإتاحة: https://doi.org/10.1016/j.annonc.2022.12.013Test
https://cris.maastrichtuniversity.nl/en/publications/7f71c7db-b119-4345-a38e-5b383cefe585Test
https://cris.maastrichtuniversity.nl/ws/files/192165470/Hendriks-2023-Non-oncogene-addicted-metastatic-non.pdfTest

المؤلفون: Hendriks, L E, Kerr, K M, Menis, J, Mok, T S, Nestle, U, Passaro, A, Peters, S, Planchard, D, Smit, E F, Solomon, B J, Veronesi, G, Reck, M

المساهمون: Hendriks, L E, Kerr, K M, Menis, J, Mok, T S, Nestle, U, Passaro, A, Peters, S, Planchard, D, Smit, E F, Solomon, B J, Veronesi, G, Reck, M

مصطلحات موضوعية: ESCAT, ESMO Clinical Practice Guideline (CPG), ESMO-MCBS, immunotherapy, non-oncogene-addicted metastatic non-small-cell lung cancer (mNSCLC), treatment, targeted therapy

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36669645; info:eu-repo/semantics/altIdentifier/wos/WOS:000982505500001; volume:34; issue:4; firstpage:358; lastpage:376; numberofpages:19; journal:ANNALS OF ONCOLOGY; https://hdl.handle.net/20.500.11768/152496Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85152568235; https://www.sciencedirect.com/science/article/pii/S0923753422047858?via=ihubTest

الإتاحة: https://doi.org/20.500.11768/152496Test
https://doi.org/10.1016/j.annonc.2022.12.013Test
https://hdl.handle.net/20.500.11768/152496Test
https://www.sciencedirect.com/science/article/pii/S0923753422047858?via=ihubTest

المؤلفون: Hendriks, L E, Kerr, K M, Menis, J, Mok, T S, Nestle, U, Passaro, A, Peters, S, Planchard, D, Smit, E F, Solomon, B J, Veronesi, G, Reck, M

المساهمون: Hendriks, L E, Kerr, K M, Menis, J, Mok, T S, Nestle, U, Passaro, A, Peters, S, Planchard, D, Smit, E F, Solomon, B J, Veronesi, G, Reck, M

مصطلحات موضوعية: ESCAT, ESMO Clinical Practice Guideline (CPG), ESMO-MCBS, oncogene-addicted metastatic non-small-cell lung cancer (mNSCLC), targeted therapy, treatment

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36872130; info:eu-repo/semantics/altIdentifier/wos/WOS:000983084800001; volume:34; issue:4; firstpage:339; lastpage:357; numberofpages:19; journal:ANNALS OF ONCOLOGY; https://hdl.handle.net/20.500.11768/152497Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85151569857; https://www.sciencedirect.com/science/article/pii/S0923753422047810?via=ihubTest

الإتاحة: https://doi.org/20.500.11768/152497Test
https://doi.org/10.1016/j.annonc.2022.12.009Test
https://hdl.handle.net/20.500.11768/152497Test
https://www.sciencedirect.com/science/article/pii/S0923753422047810?via=ihubTest